Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis
Le Yang, Shi Yue, Lin Yang, et al.
Journal of Hepatology (2013) Vol. 59, Iss. 1, pp. 114-123
Closed Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Sphingosine 1-phosphate: Lipid signaling in pathology and therapy
Andréane Cartier, Timothy Hla
Science (2019) Vol. 366, Iss. 6463
Open Access | Times Cited: 477
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
Gregory T. Kunkel, Michael Maceyka, Sheldon Milstien, et al.
Nature Reviews Drug Discovery (2013) Vol. 12, Iss. 9, pp. 688-702
Open Access | Times Cited: 411
Lysophospholipid receptor nomenclature review: IUPHAR Review 8
Yasuyuki Kihara, Michael Maceyka, Sarah Spiegel, et al.
British Journal of Pharmacology (2014) Vol. 171, Iss. 15, pp. 3575-3594
Open Access | Times Cited: 311
Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration
Ruisi Wang, Qian Ding, Usman Yaqoob, et al.
Journal of Biological Chemistry (2015) Vol. 290, Iss. 52, pp. 30684-30696
Open Access | Times Cited: 202
Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1)
Zhanping Lu, Zelin Xiao, Fabao Liu, et al.
Oncotarget (2015) Vol. 7, Iss. 1, pp. 241-254
Open Access | Times Cited: 193
The role of sphingosine 1‐phosphate receptor 2 in bile‐acid–induced cholangiocyte proliferation and cholestasis‐induced liver injury in mice
Yongqing Wang, Hiroaki Aoki, Jing Yang, et al.
Hepatology (2017) Vol. 65, Iss. 6, pp. 2005-2018
Open Access | Times Cited: 189
Hepatic macrophages: Key players in the development and progression of liver fibrosis
Da Cheng, Jin Chai, Huiwen Wang, et al.
Liver International (2021) Vol. 41, Iss. 10, pp. 2279-2294
Open Access | Times Cited: 132
Are GPCRs Still a Source of New Targets?
Stephen L. Garland
SLAS DISCOVERY (2013) Vol. 18, Iss. 9, pp. 947-966
Open Access | Times Cited: 145
Sphingosine kinase 1 promotes liver fibrosis by preventing miR‐19b‐3p‐mediated inhibition of CCR2
Tian Lan, Changzheng Li, Guizhi Yang, et al.
Hepatology (2018) Vol. 68, Iss. 3, pp. 1070-1086
Open Access | Times Cited: 133
Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS‐MS
Asem I. Fitian, David R. Nelson, Chen Liu, et al.
Liver International (2014) Vol. 34, Iss. 9, pp. 1428-1444
Open Access | Times Cited: 106
The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy
Xiangjin Zheng, Li Wan, Liwen Ren, et al.
Pharmacology & Therapeutics (2018) Vol. 195, pp. 85-99
Closed Access | Times Cited: 106
Sphingosine-1-Phosphate and Macrophage Biology—How the Sphinx Tames the Big Eater
Andreas Weigert, Catherine Olesch, Bernhard Brüne
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 102
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget
Diana Hatoum, Nahal Haddadi, Yiguang Lin, et al.
Oncotarget (2017) Vol. 8, Iss. 22, pp. 36898-36929
Open Access | Times Cited: 91
Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome
Lei Hou, Le Yang, Na Chang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 88
Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases
Hongyu Chen, Junmin Wang, Caiyun Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113341-113341
Open Access | Times Cited: 48
Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease
Leke Wiering, Pallavi Subramanian, Linda Hammerich
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 6, pp. 1277-1292
Open Access | Times Cited: 36
Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances
Giovanni Musso, Francesca Saba, Maurizio Cassader, et al.
Progress in Lipid Research (2023) Vol. 91, pp. 101238-101238
Closed Access | Times Cited: 29
Sphingosine 1-Phosphate Receptor 2 and 3 Mediate Bone Marrow-Derived Monocyte/Macrophage Motility in Cholestatic Liver Injury in Mice
Le Yang, Zhen Han, Lei Tian, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 79
Mechanisms of sphingosine 1-phosphate receptor signalling in cancer
Sathya Narayanan Patmanathan, Wei Wang, Lee Fah Yap, et al.
Cellular Signalling (2017) Vol. 34, pp. 66-75
Closed Access | Times Cited: 73
Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology
Timothy D. Rohrbach, Michael Maceyka, Sarah Spiegel
Critical Reviews in Biochemistry and Molecular Biology (2017) Vol. 52, Iss. 5, pp. 543-553
Open Access | Times Cited: 63
SPHK1 deficiency protects mice from acetaminophen-induced ER stress and mitochondrial permeability transition
Longjun Li, Haitao Wang, Jun Zhang, et al.
Cell Death and Differentiation (2019) Vol. 27, Iss. 6, pp. 1924-1937
Open Access | Times Cited: 62
MicroRNA-26b-5p Inhibits Mouse Liver Fibrogenesis and Angiogenesis by Targeting PDGF Receptor-Beta
Le Yang, Chengbin Dong, Jingjing Yang, et al.
Molecular Therapy — Nucleic Acids (2019) Vol. 16, pp. 206-217
Open Access | Times Cited: 59
EGR2-mediated regulation of m6A reader IGF2BP proteins drive RCC tumorigenesis and metastasis via enhancing S1PR3 mRNA stabilization
Yufan Ying, Xueyou Ma, Jiajie Fang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 8
Open Access | Times Cited: 56
Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-β
Alexis Paulina Jiménez‐Uribe, Tania Gómez‐Sierra, Omar Emiliano Aparicio‐Trejo, et al.
Cellular Signalling (2021) Vol. 87, pp. 110123-110123
Closed Access | Times Cited: 49
Salidroside Inhibits CCl4-Induced Liver Fibrosis in Mice by Reducing Activation and Migration of HSC Induced by Liver Sinusoidal Endothelial Cell-Derived Exosomal SphK1
Qiannan Ye, Yang Zhou, Changqing Zhao, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top